Singlomics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 26

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 15

Singlomics General Information

Description

Developer of single cell sequencing technologies for the purpose of antibody discovery. The company has developed neutralizing antibodies, DXP593 and DXP604, providing a potential solutions to fight COVID-19.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Block D, Innovation Building, Life Science Park
  • Changping District
  • Beijing
  • China
+86 010
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Block D, Innovation Building, Life Science Park
  • Changping District
  • Beijing
  • China
+86 010

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Singlomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 03-Aug-2022 Completed Clinical Trials - Phase 2
2. Early Stage VC (Series B) 14-Feb-2022 Completed Pre-Clinical Trials
1. Early Stage VC (Series A) 04-Sep-2020 $14.5M $14.5M Completed Startup
To view Singlomics’s complete valuation and funding history, request access »

Singlomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Singlomics Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Tencent Investment Corporate Venture Capital Minority
CASH Capital Venture Capital Minority
Everbright ReinFore Growth/Expansion Minority
Founder Hesheng Investment Corporate Venture Capital Minority
Legend Capital Venture Capital Minority
You’re viewing 5 of 15 investors. Get the full list »

Singlomics FAQs

  • When was Singlomics founded?

    Singlomics was founded in 2020.

  • Where is Singlomics headquartered?

    Singlomics is headquartered in Beijing, China.

  • What is the size of Singlomics?

    Singlomics has 26 total employees.

  • What industry is Singlomics in?

    Singlomics’s primary industry is Drug Discovery.

  • Is Singlomics a private or public company?

    Singlomics is a Private company.

  • What is Singlomics’s current revenue?

    The current revenue for Singlomics is .

  • How much funding has Singlomics raised over time?

    Singlomics has raised $61.6M.

  • Who are Singlomics’s investors?

    Tencent Investment, CASH Capital, Everbright ReinFore, Founder Hesheng Investment, and Legend Capital are 5 of 15 investors who have invested in Singlomics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process